Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SCTL

Societal CDMO (SCTL) Stock Price, News & Analysis

Societal CDMO logo

About Societal CDMO Stock (NASDAQ:SCTL)

Advanced Chart

Key Stats

Today's Range
$1.10
$1.10
50-Day Range
$1.06
$1.10
52-Week Range
$0.26
$1.28
Volume
N/A
Average Volume
957,342 shs
Market Capitalization
$116.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services. It also offers regulatory support, including handling communications with the food and drug administration (FDA) and seek consultation and guidance for client FDA meetings and responses; and pharmaceutical packaging and logistics, as well as smaller-scale primary and secondary packaging, labeling and kitting options suited for clinical trial materials and development packaging needs across dosage forms. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Receive SCTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Societal CDMO and its competitors with MarketBeat's FREE daily newsletter.

SCTL Stock News Headlines

Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
See More Headlines

SCTL Stock Analysis - Frequently Asked Questions

Societal CDMO, Inc. (NASDAQ:SCTL) announced its quarterly earnings results on Friday, March, 22nd. The company reported ($0.01) EPS for the quarter. The firm earned $27.72 million during the quarter, compared to the consensus estimate of $25.50 million. Societal CDMO had a negative net margin of 14.03% and a negative trailing twelve-month return on equity of 23.82%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Societal CDMO investors own include Applied DNA Sciences (APDN), Sunworks (SUNW), Meta Platforms (META), PayPal (PYPL), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Pfizer (PFE).

Company Calendar

Last Earnings
3/22/2024
Today
5/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SCTL
Employees
258
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,270,000.00
Pretax Margin
-13.89%

Debt

Sales & Book Value

Annual Sales
$94.64 million
Price / Cash Flow
N/A
Book Value
$0.56 per share
Price / Book
1.96

Miscellaneous

Free Float
97,658,000
Market Cap
$116.26 million
Optionable
Optionable
Beta
1.61
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SCTL) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners